When Lifelong Anosmia Reveals Hypogonadism: A Case of Kallmann Syndrome with Primary Amenorrhea. [PDF]
Lubis JYG +3 more
europepmc +1 more source
ABSTRACT Females who have larger bodies or obesity may be at an increased risk for experiencing infertility. Problematically, both weight or body size and infertility are stigmatized, harming quality of care. We conducted a scoping review to understand the lived experiences of patients who may be subjected to intersecting stigmas of weight and ...
Brooke J. Hebert +16 more
wiley +1 more source
Comparing ovulation induction strategies for unexplained infertility: protocol for a systematic review and network meta-analysis. [PDF]
Mehta P +4 more
europepmc +1 more source
Function of anti-müllerian hormone (AMH), gonadotropins and FSHR rs6166 genetic variant in the pathogenesis and diagnostic assessment of polycystic ovary syndrome. [PDF]
Albaldawy MT +3 more
europepmc +1 more source
Cytologic Characteristics of the Feline Ovary at Different Sexual Stages
ABSTRACT Background Cytology is a valuable diagnostic tool in veterinary medicine, allowing rapid and minimally invasive diagnosis. However, its application in the reproductive tracts of small animals is limited, primarily used to assess mammary masses and stage the estrous cycle.
Alba Martí +4 more
wiley +1 more source
Macrohormones in endocrinology: prevalence, clinical impact, and diagnostic approaches. [PDF]
Bronisławska A +6 more
europepmc +1 more source
Menopause and vascular endothelial health: Is it all about the oestrogen?
Abstract Cardiovascular disease (CVD) is a leading cause of mortality in women, and CVD risk is accelerated during the menopause transition. This acceleration has traditionally been attributed to the hallmark decline in oestradiol with menopause. However, the menopause transition is also characterized by changes in other sex hormones that exert effects
Virginia R. Nuckols +4 more
wiley +1 more source
Ovarian antral follicle dynamics from birth through reproductive maturity: a mini-review. [PDF]
Lamar H, Cardoso R, Vanden Brink H.
europepmc +1 more source
Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan +4 more
wiley +1 more source

